Tofacitinib (Xeljanz): Used for rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Baricitinib (Olumiant): Approved for alopecia areata and rheumatoid arthritis.

Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, ... about 10% develop inflammatory bowel conditions like Crohn’s disease or ulcerative colitis.

And again, I would say that the wonderful part of this, is the experience that we have had in our other diseases, rheumatoid arthritis and ulcerative colitis, you can in your psoriatic arthritis ...

Ulcerative colitis adverse reactions: induction (≥2%): respiratory tract infections; maintenance (≥3%): injection site reactions, arthralgia, and upper respiratory tract infections.

The monoclonal antibody may exert its clinical effects in psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease through interruption of the Th1 and Th17 cytokine pathways, ...

Hyrimoz HCF (100 mg/ml) is approved to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque ...

Guselkumab is the first approved fully-human monoclonal antibody that blocks IL-23 by binding to the p19 subunit of IL-23. IL-23 is a cytokine secreted by activated monocyte/macrophages and ...

For jPsA, the application utilised pharmacokinetic extrapolation analyses from adult psoriatic arthritis studies, DISCOVER 1 and 2, alongside data from the PROTOSTAR study.

PARSIPPANY, N.J. and REYKJAVÍK, Iceland, Feb. 21, 2025-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Alvotech today announced the availability of SELARSDI ...

-- EQUATOR Achieves Primary Endpoint of ACR20 Response at Week 16 -- -- Galapagos to Receive $15 Million Payment from Gilead for Progression into Phase 3 of the Phase 2b/3 SELECTION Study of ...